Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer

Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer

US Patent 10583129 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective EP4 receptor antagonistic substance for treatment of cancer2023
Selective EP4 receptor antagonistic substance for treatment of cancer2023
Uses of benzimidazole derivative for nocturnal acid breakthrough2021
EP4 inhibitors and use thereof2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Use of EP4 receptor antagonists in the treatment of cartilage disease2020
Selective EP4 receptor antagonistic substance for treatment of cancer2020
Selective EP4 receptor antagonistic substance for treatment of cancer2020
Uses of benzimidazole derivative for nocturnal acid breakthrough2019
Use of EP4 receptor antagonists in the treatment of cartilage disease2019
Use of EP4 receptor antagonists for the treatment of NASH-associated liver cance2019